Cargando…
Mutations in variable domains of the HIV-1 envelope gene can have a significant impact on maraviroc and vicriviroc resistance
BACKGROUND: Resistance to CCR5 inhibitors, such as maraviroc and vicriviroc is characterized by reduction of maximal percent inhibition which indicates the use of an inhibitor-bound conformation of CCR5 for human immunodeficiency virus-1(HIV-1) entry. It is accompanied by substitutions in gp120 and...
Autores principales: | Asin-Milan, Odalis, Chamberland, Annie, Wei, Yi, Haidara, Alpha, Sylla, Mohamed, Tremblay, Cécile L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3700831/ https://www.ncbi.nlm.nih.gov/pubmed/23758814 http://dx.doi.org/10.1186/1742-6405-10-15 |
Ejemplares similares
-
HIV-1 envelope sequence-based diversity measures for identifying recent infections
por: Kafando, Alexis, et al.
Publicado: (2017) -
HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses
por: Kafando, Alexis, et al.
Publicado: (2019) -
A Short-Term Assessment of Nascent HIV-1 Transmission Clusters Among Newly Diagnosed Individuals Using Envelope Sequence-Based Phylogenetic Analyses
por: Kafando, Alexis, et al.
Publicado: (2019) -
Maraviroc in the treatment of HIV infection
por: Ray, Neelanjana
Publicado: (2009) -
Use of maraviroc in patients with undetectable viral load: efficacy, tolerance and predictors of viral response in MARAVIROC-cohort study
por: Jesús Pérez Elías, María, et al.
Publicado: (2014)